ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI To Evaluate Chernobyl Effects On Soviet Health

November 23, 1990

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Community Tobacco Control Intervention Grants Funded By NCI.

October 27, 2000

In Brief: Wells Tapped For GM Cancer Foundation; Calder Named NABCO Associate Director

January 17, 1997